Key result
Implantable cardioverter defibrillators have undergone significant design modifications since 1980 and are now an indispensable, guideline-directed therapy for preventing sudden cardiac death.
Why the study?
ICD design, applications, and indications have continuously expanded, prompting a review of their evolutionary milestones, current indications, recent advances, and future directions.
Answers are grounded in this paper and cite their sources.
This review highlights the historical evolution, current guideline-based indications, and future technological advancements of implantable cardioverter defibrillators in managing ventricular arrhythmias and preventing sudden cardiac death.
Since their formal introduction in 1980, implantable cardioverter defibrillators (ICDs) have undergone innumerable design modifications through several generations. They are indispensable today in successfully managing fatal ventricular arrhythmias. Their role in averting sudden cardiac death is recognized beyond doubt. Their applications and indications have continuously expanded over the last two decades. This article reviews the salient features in the evolution of ICDs, their current indications, recent advances and future directions. With more advanced detection algorithms, the potential integration with leadless pacing, and the possibility to serve as a remote monitoring device to recognize atrial fibrillation, acute ischemia, or electrolyte imbalance, the application of ICDs is rapidly evolving.
No takes yet. Share an insight, caveat, or question.
Ganesh Kumar K. Ammannaya (2020) conducted a review in Ventricular arrhythmias and sudden cardiac death. Implantable cardioverter defibrillators (ICDs) was evaluated. Implantable cardioverter defibrillators have undergone significant design modifications since 1980 and are now an indispensable, guideline-directed therapy for preventing sudden cardiac death.
Synapse has enriched 10 related papers. Consider them for comparative context: